Albert Marchetti
Overview
Explore the profile of Albert Marchetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Joshi S, Mohan V, Joshi S, Mechanick J, Marchetti A
Curr Diab Rep
. 2012 Feb;
12(2):204-12.
PMID: 22354498
India and other countries in Asia are experiencing rapidly escalating epidemics of type 2 diabetes (T2D) and cardiovascular disease. The dramatic rise in the prevalence of these illnesses has been...
12.
Su H, Tsang M, Huang S, Mechanick J, Sheu W, Marchetti A
Curr Diab Rep
. 2012 Feb;
12(2):213-9.
PMID: 22311609
The prevalence of type 2 diabetes (T2D) in Asia is growing at an alarming rate, posing significant clinical and economic risk to health care stakeholders. Commonly, Asian patients with T2D...
13.
Marchetti A, Rossiter R
J Med Econ
. 2009 Nov;
12(4):384-91.
PMID: 19916738
Background: Acetaminophen (APAP) overdose, which can lead to hepatotoxicity, is the most commonly reported poisoning in the United States and has the highest rate of mortality, with more than 100,000...
14.
Salber P, Bestermann W, Schwartz S, Marchetti A
Manag Care
. 2008 Nov;
17(10):38-46.
PMID: 18990924
Unlabelled: Using current treatment approaches, many patients with type 2 diabetes do not achieve glycemic goals--and do experience macrovascular complications that contribute to morbidity and mortality. It's time to consider...
15.
Marchetti A, Jacobs J, Young M, Martin J, Rossiter R
Curr Med Res Opin
. 2007 Feb;
23(1):9-16.
PMID: 17285737
Background: The economic implications of inpatient adverse events and rising healthcare costs have intensified interest in patient safety and the efficient delivery of products and services with cost-saving potential. New...
16.
Brashear A, Hogan P, Wooten-Watts M, Marchetti A, Magar R, Martin J
Adv Ther
. 2005 Jun;
22(1):49-55.
PMID: 15943222
Botulinum toxin type A (BoNT/A) is the principal therapy for patients with cervical dystonia. Repeated treatments over many years are required in most cases. This retrospective review evaluates the dose...
17.
Marchetti A, Magar R, Findley L, Larsen J, Pirtosek Z, Ruzicka E, et al.
Mov Disord
. 2005 Apr;
20(8):937-44.
PMID: 15810022
The purpose of this study is to evaluate the real-world dose utilization of Dysport and BOTOX for cervical dystonia and blepharospasm. Six investigational sites (five countries) were identified. Investigators abstracted...
18.
Marchetti A, Feldman S, Kimball A, Anderson R, Miller L, Martin J, et al.
Dermatol Online J
. 2005 Mar;
11(1):1.
PMID: 15748542
The cost effectiveness of treatments for psoriasis has been evaluated previously by several different investigators. Such evaluations should be updated as new products or data become available. To this end,...
19.
Peters Harmel A, Kendall D, Buse J, Boyle P, Marchetti A, Lau H
Curr Med Res Opin
. 2004 Mar;
20(2):215-23.
PMID: 15006017
Objective: This study was undertaken to assess the effect of pioglitazone hydrochloride and rosiglitazone maleate on blood lipid levels and glycemic control when these drugs are used as adjunctive therapy...
20.
Olansky L, Marchetti A, Lau H
Clin Ther
. 2003 Oct;
25 Suppl B:B64-80.
PMID: 14553867
Background: Thiazolidinediones (TZDs) have contributed to the management of patients with type 2 diabetes mellitus as unique insulin-sensitizing agents. When used as monotherapy or in combination therapy, these drugs not...